Clinical Trials Directory

Trials / Unknown

UnknownNCT03212872

Blood Ammonia as Predictor for Esophageal Varices and Risk of Bleeding

Evaluation of Blood Ammonia Level as a Non Invasive Predictor for Presence of Gastroesophageal Varices and Risk of Bleeding

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
Tanta University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Assessment of blood ammonia level as a non-invasive predictor for presence of EV and risk of bleeding

Detailed description

A prospective cross sectional study on 150 consecutive patients screening for esophageal varices. Patient groups groups: Group (1): 100 patients with esophageal varices Group (2): 50 chronic liver disease patients with no esophageal varices as a control group. All patients will be subjected to: 1. \- Detailed history-taking 2. \- Full clinical examination 3. \- Laboratory investigations: * Complete blood picture (CBC) * Erythrocyte sedimentation rate (ESR) * Renal function tests * Liver function tests * Prothrombin time and activity * Viral markers (HCV Ab - HBV Ag) * Blood ammonia level. 4. \- Pelviabdominal US: Ultrasound examination of the liver, portal venous system, spleen, kidney and other abdominal organs. 5. \- Upper GITendoscopy: * Varices will be classified according to the Japanese classification 1996, * The Baveno 11 score will be used to differentiate between mild and severe portal hypertensive gastropathy.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTEndoscopy

Timeline

Start date
2016-07-07
Primary completion
2018-12-31
Completion
2018-12-31
First posted
2017-07-11
Last updated
2017-07-11

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03212872. Inclusion in this directory is not an endorsement.

Blood Ammonia as Predictor for Esophageal Varices and Risk of Bleeding (NCT03212872) · Clinical Trials Directory